The invention provides application of a compound for regulating and controlling an METTL3 target spot in preparation of an anti-
enterovirus drug, and belongs to the field of biological
medicine, the compound is AN-465 / 42162872, and the compound has a relatively strong anti-EV71 effect in both in-vitro and in-vivo infection models. An in-vitro
cell experiment, EV71 infected C57BL / 6 suckling mouse model, m6A
methylation sequencing and other methods are utilized to research the activity and potential action mechanism of anti-EV71, and the result shows that AN-465 / 42162872 can inhibit duplication of EV71 in a human RD
cell strain in a
dose-
dependent manner under the condition of maintaining relatively good
cell activity, so that the application of AN-465 / 42162872 in the preparation of the EV71
drug is developed. The action mechanism is mainly as follows: the
methylation level of the 5002 adenine in the 2
C region of EV71
nucleic acid is remarkably reduced by regulating the METTL3, so that
virus replication is inhibited, and the METTL3 has relatively high anti-EV71
drug utilization value.